Guizhou Xinbang Pharmaceutical Co., Ltd. (SHE:002390)
China
· Delayed Price · Currency is CNY 3.350
+0.030 (0.90%)
At close: Mar 10, 2026
SHE:002390 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 6,353 | 8,629 | 8,560 | 9,136 | 14,423 | 13,431 | Upgrade
|
| Market Cap Growth | -19.47% | 0.81% | -6.31% | -36.66% | 7.39% | 58.53% | Upgrade
|
| Enterprise Value | 6,140 | 8,820 | 8,932 | 9,841 | 15,454 | 15,772 | Upgrade
|
| Last Close Price | 3.35 | 4.47 | 4.26 | 4.46 | 6.95 | 7.94 | Upgrade
|
| PE Ratio | 87.82 | 85.11 | 29.80 | 40.72 | 52.86 | 77.40 | Upgrade
|
| Forward PE | - | 26.33 | 26.33 | 29.35 | 29.35 | 29.35 | Upgrade
|
| PS Ratio | 1.11 | 1.43 | 1.33 | 1.44 | 2.23 | 2.30 | Upgrade
|
| PB Ratio | 0.91 | 1.23 | 1.20 | 1.29 | 2.11 | 2.60 | Upgrade
|
| P/TBV Ratio | 1.07 | 1.46 | 1.41 | 1.52 | 2.49 | 3.28 | Upgrade
|
| P/FCF Ratio | 11.11 | 16.92 | 13.07 | 21.15 | 70.63 | 22.24 | Upgrade
|
| P/OCF Ratio | 9.53 | 13.59 | 10.83 | 15.46 | 31.49 | 18.10 | Upgrade
|
| EV/Sales Ratio | 1.07 | 1.46 | 1.38 | 1.55 | 2.39 | 2.70 | Upgrade
|
| EV/EBITDA Ratio | 13.69 | 17.96 | 14.41 | 17.33 | 20.14 | 24.83 | Upgrade
|
| EV/EBIT Ratio | 24.58 | 31.18 | 22.84 | 29.57 | 29.24 | 39.08 | Upgrade
|
| EV/FCF Ratio | 10.74 | 17.29 | 13.64 | 22.78 | 75.68 | 26.11 | Upgrade
|
| Debt / Equity Ratio | 0.08 | 0.11 | 0.12 | 0.20 | 0.21 | 0.66 | Upgrade
|
| Debt / EBITDA Ratio | 1.17 | 1.58 | 1.33 | 2.42 | 1.82 | 5.37 | Upgrade
|
| Debt / FCF Ratio | 0.92 | 1.54 | 1.28 | 3.22 | 6.93 | 5.65 | Upgrade
|
| Net Debt / Equity Ratio | -0.06 | -0.03 | 0.00 | 0.07 | 0.12 | 0.32 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.99 | -0.46 | 0.05 | 0.87 | 1.03 | 2.57 | Upgrade
|
| Net Debt / FCF Ratio | -0.76 | -0.45 | 0.05 | 1.14 | 3.87 | 2.71 | Upgrade
|
| Asset Turnover | 0.66 | 0.66 | 0.68 | 0.65 | 0.67 | 0.58 | Upgrade
|
| Inventory Turnover | 5.18 | 4.85 | 5.15 | 5.22 | 5.76 | 5.00 | Upgrade
|
| Quick Ratio | 2.81 | 2.23 | 2.02 | 1.65 | 1.56 | 1.12 | Upgrade
|
| Current Ratio | 3.58 | 2.91 | 2.63 | 2.16 | 2.02 | 1.36 | Upgrade
|
| Return on Equity (ROE) | 1.76% | 2.20% | 4.98% | 3.86% | 6.23% | 4.32% | Upgrade
|
| Return on Assets (ROA) | 1.79% | 1.93% | 2.57% | 2.14% | 3.43% | 2.51% | Upgrade
|
| Return on Invested Capital (ROIC) | 3.19% | 3.40% | 4.74% | 3.75% | 6.51% | 4.60% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.50% | 3.90% | 5.40% | 4.70% | 7.70% | 7.80% | Upgrade
|
| Earnings Yield | 1.21% | 1.18% | 3.36% | 2.46% | 1.89% | 1.29% | Upgrade
|
| FCF Yield | 9.00% | 5.91% | 7.65% | 4.73% | 1.42% | 4.50% | Upgrade
|
| Dividend Yield | 1.81% | 1.34% | 1.41% | 1.35% | 0.86% | - | Upgrade
|
| Payout Ratio | 231.87% | 189.67% | 55.09% | 75.03% | 84.41% | 113.85% | Upgrade
|
| Buyback Yield / Dilution | -7.11% | -5.89% | -2.41% | -2.79% | -15.32% | -0.14% | Upgrade
|
| Total Shareholder Return | -5.31% | -4.55% | -1.00% | -1.44% | -14.46% | -0.14% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.